Keystone Heart is focused on protecting the brain from emboli to reduce the risk of brain infarcts during TAVR, atrial fibrillation ablation and other structural heart procedures.

Latest News

Share this

Author: Keystone Heart

TCT 2017 Breakfast Symposium

Please mark your calendars to attend the Keystone Heart Breakfast Symposium at TCT 2017 Introducing Progress in Cerebral Embolic Protection Wednesday, November 1st Program check-in and breakfast begins at 6:30AM Program will run from 7:00AM-8:00AM. Co-chaired by Raj Makkar and Tamim Nazif Colorado Convention Center Room 501 AGENDA 1. Dr. Pieter Stella - Critical review of...

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

New third-generation cerebral embolic protection device offers improvements to further guard the brain from emboli during heart procedures including TAVR   CAESAREA, Israel, and TAMPA, Florida — August 1st, 2017 —  Keystone Heart Ltd., an emerging medical device company focused on developing cerebral protection devices for patients...


CSI, Imaging & Innovation 2017

Friday June 30, 2017 Frankfurt, Germany Main Room of the Congress Center CSI, Imaging & Innovation 2017 Parallel Sessions Seminar: Challenges with TAVI Moderator: David Hildick-Smith, MD / Nalan Schnelle, MD Agenda: 10:30-12:40 New standards for assessing neurologic damage in CV clinical trials - Andreas Baumbach, MD Can we calculate the cost benefit ratio of...

euro pcr

EuroPCR 2017 Symposium

Wednesday 17 May 2017 Paris, France Protecting the Brain; While Treating the Heart Sponsored by Keystone Heart 13:35-14:35 Room 352B Attend this session if you want to: • Understand the clinical need for cerebral embolic protection during cardiovascular procedures • Learn about the clinical evidence surrounding cerebral embolic protection and the clinical...